The latest data for the central bank’s preferred inflation gauge showed a slight uptick, but the long-term inflation trend remains favorable. Read More
Analyst Articles
Health and Human Services announced this week that it’s asking the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III. Read More
Our editorial director answers letters from readers on a range of investment topics, with advice of universal applicability. Read More
Instead of the mega-cap plays on artificial intelligence, consider this lesser-known stock that embeds military might with AI innovation. Read More
September-October is historically the worst-performing period of the year for the stock market. Here’s a look at this seasonal effect. Read More
Instead of the multi-billion-dollar deals that grabbed headlines in the past, we’ll see a slew of smaller transactions in coming months. Read More
The stock market rally remains alive, but we’re seeing increased volatility and worsening investor anxiety. Here’s how to trade, amid the mix of good and bad news. Read More
Fed Chair Jerome Powell gave his highly anticipated remarks Friday and they were hawkish, indicating a rough road ahead for investors. Read More
Consumption rates among Americans of marijuana and hallucinogenic substances are at historic levels. Investors are taking notice. Read More
As the blow-out Q2 operating results of chipmaker Nvidia attest, artificial intelligence already pervades our lives and investing decisions. Read More